1620775-45-2

Upstream product

• 1620775-44-1 C₅⁽²⁾H₂Cl₂F₃N₃O 
• 619-45-4 4-methoxycarbonyl aniline 

Downstream Products

• 1620775-42-9 4-(4-(1-(4-chlorophenyl)cyclopropylamino)-6-(2,2,2-trifluoroethoxy-D₂)-1,3,5-triazin-2-ylamino)benzoic acid 
• 1620775-47-4 4-(4-(1-(4-chlorophenyl)cyclopropylamino)-6-(2,2,2-trifluoroethoxy-D₂)-1,3,5-triazin-2-ylamino)benzoyl chloride 
• 1620775-30-5 2-(4-(4-(1-(4-chlorophenyl)cyclopropylamino)-6-(2,2,2-trifluoroethoxy-D₂)-1,3,5-triazin-2-ylamino)benzamido)-N,N,N-trimethylethanaminium 
• 1620775-46-3 methyl 4-(4-(1-(4-chlorophenyl)cyclopropylamino)-6-(2,2,2-trifluoroethoxy-D₂)-1,3,5-triazin-2-ylamino)benzoate 
• 1620786-10-8 C₂₇H₂₈⁽²⁾H₂ClF₃N₁₀O₃ 

Relevant academic research and scientific papers

AMMONIUM DERIVATIVES FOR THE TREATMENT OF HEPATITIS C

Compounds of Formula I, including pharmaceutically acceptable salts thereof, are set forth, in addition to compositions and methods of using these compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those i

GUANIDINE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C

Compounds of Formula I, including pharmaceutically acceptable salts thereof, are set forth, in addition to compositions and methods of using these compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.